Send Message
View as an RSS Feed
  • ImmunoCellular's lead product candidate barely beats placebo in mid-stage study; subgroup of patients targeted for Phase 3; shares down 13%  [View news story]
    How many of the 81 patients treated by ICT 107 survived until today?
    Nov 20, 2015. 01:33 PM | Likes Like |Link to Comment
  • Mallinckrodt's Acthar Gel flunks pilot study in Lupus patients  [View news story]
    Oh why did I hold on to my QCOR shares (now MNK) for so long :(
    Nov 9, 2015. 02:15 PM | 1 Like Like |Link to Comment
  • Point72 hikes SunEdison stake to 5.1%; shares rise  [View news story]
    Good news, hopefully the stock will recover, my average is 13.8, started accumulating to soon at 20!
    Aug 31, 2015. 04:54 PM | Likes Like |Link to Comment
  • Galena faces the obligatory lawsuits  [View news story]
    I think GALE is alright, nothing major. This reminds me of QCOR, Citron wrote an article, investigation on promotion practices went on created a buying opportunity at 18, now it's close to 80.
    Mar 7, 2014. 07:46 AM | Likes Like |Link to Comment
  • Rexahn Pharmaceuticals: Another $1.30 Biotech Lottery Ticket  [View article]
    I think if RNN can soon explode, a 20% difference in your cost average would not be much. However, I do think that RNN would be pretty much in a calm period over the next few months since the trials have just started and no short term catalyst.

    I myself would not dilute 20% share holder value if I think the price would increase dramatically in short term period, at least I would do a shelf offering to wait for better moment to raise capital
    Feb 27, 2014. 01:13 PM | Likes Like |Link to Comment
  • Inovio continues sharply lower after secondary offering  [View news story]
    455M for 19M shares, that's 29USD/share, I'll take that!
    Feb 27, 2014. 12:58 PM | Likes Like |Link to Comment
  • Rexahn Pharmaceuticals: Another $1.30 Biotech Lottery Ticket  [View article]
    Bret, thanks for your article,

    I believe 1.30 is a little too expensive and not a good entry point for RNN right now since it is very volatile. I guess it can certainly settle in a few days around 1.10 and it would make a good entry point.

    I do agree with the longer term prospect of the company, though, I am long from 98c
    Feb 27, 2014. 12:22 PM | 5 Likes Like |Link to Comment
  • Trading in Amarin shares halted ahead of FDA advisory meeting  [View news story]
    Actually this is normal, they did it last time too.
    Oct 16, 2013. 09:34 AM | Likes Like |Link to Comment
  • GE wins $1B booking from Vietnam for 787 engines  [View news story]
    Well, I guess the aircraft would have shorter range as a consequence. Right now, VNA does not have direct flight to USA, I don't think that would be changed soon.
    Sep 29, 2013. 10:19 AM | 1 Like Like |Link to Comment
  • Inovio - Dilution And Catalysts Make It A Promising Short  [View article]
    I can't help laughing...

    The market cap of Ino is less than 500M and the deal signed with Roche might worth upper 400M alone, that's just 2 of the 10 drugs in INO's pipeline plus royalties on usage of the technology!

    Guess what? INO still has 7 other drugs/vaccines to be partnered with, including 3 products targetting HIV, various type of flu...

    How many more partnerships are needed to show the bashers the potential of INO?
    Sep 10, 2013. 11:22 AM | 3 Likes Like |Link to Comment
  • Amarin Regains Ahead Of Vital Q4 Catalysts  [View article]
    It normally happens the same day, they will vote on the same day.
    Sep 4, 2013. 12:36 PM | Likes Like |Link to Comment
  • A roundup of tech analyst ratings changes  [View news story]
    Bernstein even talked trash in the CC today! He was like "why does NOK need 1.5B financing", I find that pretty stupid since NOK current debt rating is very low and MSFT credit facility would have much smaller interest rate.
    Sep 3, 2013. 01:38 PM | Likes Like |Link to Comment
  • Inovio Pharmaceuticals soars on no specific news driver today  [View news story]
    There is a new driver, there's a conference annoucement for a conference in Korea on Sep 11, speaker would be member of INO scientific board (and 2nd largest individual investor of INO), Merck would be there also talking about... vaccine licensing
    Aug 21, 2013. 04:47 PM | Likes Like |Link to Comment
  • Intellipharmaceutics: A Bio-Better Generics Play On The Cutting Edge  [View article]
    WOW, I recouped my loss and made some profit today on no news with IPCI! Is Focalin or possilbly 2-3 other drugs getting approved or what?
    Jul 23, 2013. 01:38 PM | Likes Like |Link to Comment
  • Intellipharmaceutics: A Bio-Better Generics Play On The Cutting Edge  [View article]
    I am IPCI long but the company will run out of cash soon and they need the Focalin XR to be approved NOW so that cash can come from partner PAR, otherwise it's gonna be yet another dillution!
    Jul 17, 2013. 11:30 AM | 1 Like Like |Link to Comment